arrow
Y

Ying K. Tam

acuitas therapeutics
H指数:62
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies

增强B细胞初始刺激诱导广泛中和HIV-1顶点抗体

Nature
IF48.5
2026-06-300
PRE
RNA-LNP–mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I

RNA-LNP介导的在体基础编辑纠正了鸟氨酸氨甲酰转移酶缺乏症小鼠模型的疾病表型

2026-05-130
PRE
Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses

mRNA疫苗的不同组分协同作用,指导高效的生发中心反应

Cell
IF42.5
2025-12-160
PREAI
Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice

计算设计的mRNA启动的蛋白质纳米颗粒免疫原在 mice 中诱导保护性抗体和T细胞应答

2025-10-150
PRE
Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques

基于嵌合血凝素的全能流感mRNA疫苗在恒河猴中诱导保护性免疫和骨髓浆细胞

2025-09-250
OAAI
mRNA-LNP vaccine encoding the Plasmodium vivax circumsporozoite protein is highly immunogenic and confers protection in mice

编码恶性疟原虫环子孢子蛋白的mRNA-LNP疫苗具有高度免疫原性,并能在小鼠中提供保护。

2025-07-300
OAAI
mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models

mRNA-LNP疫苗在预防性和慢性小鼠挑战模型中诱导保护性免疫反应

2025-06-140
OAAI
An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses

一种Il12 mRNA-LNP佐剂增强了mRNA疫苗诱导的CD8 T细胞反应

2025-06-060
PRE
Treatment of a metabolic liver disease in mice with a transient prime editing approach

使用暂时性碱基编辑方法治疗小鼠的代谢性肝病

2025-05-200
OA
Monitoring mRNA vaccine antigen expression in vivo using PET/CT

使用PET/CT监测mRNA疫苗抗原在体内的表达

2025-03-061
OA
Staggered immunization with mRNA vaccines encoding SARS- CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire

编码传染性非典型肺炎CoV-2聚合酶或刺突抗原的mRNA疫苗的交错预防接种扩大了T细胞表位库

2024-11-260
OAAI